A detailed history of Nea Management Company, LLC transactions in Verona Pharma PLC stock. As of the latest transaction made, Nea Management Company, LLC holds 5,108,563 shares of VRNA stock, worth $61.7 Million. This represents 5.77% of its overall portfolio holdings.

Number of Shares
5,108,563
Previous 5,108,563 -0.0%
Holding current value
$61.7 Million
Previous $102 Million 19.06%
% of portfolio
5.77%
Previous 7.4%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

SELL
$19.41 - $23.43 $9.24 Million - $11.2 Million
-476,190 Reduced 8.53%
5,108,563 $108 Million
Q3 2022

Nov 14, 2022

BUY
$4.14 - $13.59 $1.97 Million - $6.47 Million
476,190 Added 9.32%
5,584,753 $57.1 Million
Q3 2020

Nov 06, 2020

BUY
$4.45 - $10.2 $17.3 Million - $39.7 Million
3,888,889 Added 318.85%
5,108,563 $31.9 Million
Q3 2017

Nov 03, 2017

BUY
$11.96 - $16.95 $14.6 Million - $20.7 Million
1,219,674
1,219,674 $18.7 Million

Others Institutions Holding VRNA

About Verona Pharma plc


  • Ticker VRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,954,200
  • Market Cap $736M
  • Description
  • Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...
More about VRNA
Track This Portfolio

Track Nea Management Company, LLC Portfolio

Follow Nea Management Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nea Management Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nea Management Company, LLC with notifications on news.